{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-027236","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2023-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.783572+00:00","generated_at":"2026-06-14T11:30:02.783028+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"SANUWAVE appoints Morgan Frank as interim CEO; Kevin Richardson becomes Chief Strategy Officer","bullets":["Morgan Frank appointed interim CEO effective 5/23/23; he is Chairman and founder of Manchester Explorer Fund (largest shareholder).","Frank will receive $1/year base salary; eligible for incentive bonus and benefit plans.","Kevin Richardson steps down as CEO, stays as Chief Strategy Officer for up to 12 months; receives options for 25 million shares (half vest immediately, half on 4/15/24).","Pro-rated annual bonus tied to 2023 goals: $30M sales, $3M adjusted EBITDA, Nasdaq/NYSE listing; severance of 20 weeks' salary if terminated without cause."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-027236","json":"https://secwatch.observer/filing/0001140361-23-027236.json","markdown":"https://secwatch.observer/filing/0001140361-23-027236.md","text":"https://secwatch.observer/filing/0001140361-23-027236.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000114036123027236/0001140361-23-027236-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000114036123027236/brhc20053597_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T11:30:02.783028+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"be1544c017","claim":"Kevin A. Richardson, II changed role as Chief Strategy Officer at SANUWAVE Health, Inc..","evidence_excerpt":"Mr. Frank will succeed Kevin A. Richardson, II, the former Chief Executive Officer of the Company, who stepped down as Chief Executive Officer on May 23, 2023 to serve as the Company’s Chief Strategy Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036123027236/0001140361-23-027236-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chief Strategy Officer"}],"fact_type":"executive_change"},{"claim_id":"d40d20261d","claim":"Morgan Frank was appointed as interim Chief Executive Officer at SANUWAVE Health, Inc..","evidence_excerpt":"Effective May 23, 2023, the Board of Directors (the “Board”) of SANUWAVE Health, Inc. (the “Company”) appointed Morgan Frank, age 51, the current Chairman of the Board, as the Company’s interim Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036123027236/0001140361-23-027236-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}